“There are thousands of CARTO 3 Systems throughout the world containing data that could unlock new clinical insights, refinements to procedures, and personalized education and training,” said Uri Yaron, Worldwide President of Biosense Webster, Inc. “CARTONET is the key to that vast data and we are confident it will be an ongoing source of meaningful innovation to elevate the standard of care.”
About Johnson & Johnson Medical Devices Companies
As the world’s most comprehensive medical devices business, we are building on a century of experience, leveraging science and technology, to shape the future of healthcare. With unparalleled breadth, depth and reach in surgery, orthopaedics, vision and interventional solutions we are working to profoundly change the way care is delivered. We are in this for life.
About Biosense Webster, Inc.
Biosense Webster, Inc. is a global leader in the science of diagnosing and treating heart rhythm disorders. The company partners with clinicians to develop innovative technologies that improve the quality of care for arrhythmia patients worldwide. Biosense Webster, Inc. is part of the Johnson & Johnson Family of Companies.
Back to HCB News
